Real-time enrollment status for this moderate to severe chronic obstructive pulmonary disease clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 10:35 AM UTC
| NCT Number | NCT07363694 |
| Recruiting Status | Recruiting |
| Condition | Moderate to Severe Chronic Obstructive Pulmonary Disease |
| Phase | PHASE2 |
| Target Enrollment | 1,156 participants |
| Active Locations | 57 sites in the US |
| Sponsor | Pfizer |
| Last Updated on CT.gov | July 27, 2026 (Jul 27, 2026) |
As of August 27, 2026: Clinical trial NCT07363694 is currently recruiting participants. This phase2 study for moderate to severe chronic obstructive pulmonary disease is actively seeking new participants at 57 locations across the United States. The study is sponsored by Pfizer. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07363694 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 57 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07363694 was last updated Jul 27, 2026 (July 27, 2026). HelloStudys verifies this status automatically.